Clinical trial
Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis
NCT02271958 is registered in ClinicalTrials.gov with Mediterranea Medica S. L. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis
- Lead sponsor
- Mediterranea Medica S. L.
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- December 31, 2013
- Enrollment
- 360 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.